Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.35%169.55M | -14.61%156.11M | 12.84%179.43M | 12.67%752.45M | 33.69%233.37M | 7.72%177.26M | 8.31%182.82M | -0.58%159M | -18.01%667.84M | 21.60%174.56M |
| Cost of revenue | -5.59%444.96M | 7.96%471.31M | ||||||||
| Gross profit | 56.46%307.49M | -48.01%196.53M | ||||||||
| Operating expense | -2.59%102.36M | -11.27%128.85M | 35.78%148.96M | -50.02%36.55M | -17.55%121.5M | -8.30%105.08M | -6.21%145.22M | -14.05%109.7M | -34.16%73.12M | 145.84%147.37M |
| Selling and administrative expenses | ---- | ---- | ---- | 21.17%95.92M | ---- | ---- | ---- | ---- | -25.99%79.16M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | 28.28%61.76M | ---- | ---- | ---- | ---- | -35.48%48.15M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 10.14%34.16M | ---- | ---- | ---- | ---- | -4.08%31.01M | ---- |
| Other operating expenses | 8.62%131.22M | -11.89%128.85M | 19.52%148.96M | -30.52%18.57M | 1.25%149.21M | -8.82%120.8M | -5.55%146.24M | -6.04%124.63M | -43.23%26.73M | 137.58%147.37M |
| Total other operating income | 83.59%28.86M | ---- | ---- | 137.88%77.94M | --27.71M | -12.17%15.72M | --1.02M | 198.42%14.92M | -23.75%32.77M | ---- |
| Operating profit | -6.91%67.19M | -27.50%27.26M | -38.21%30.46M | 119.55%270.94M | 311.41%111.87M | 44.47%72.18M | 169.34%37.59M | 52.64%49.3M | -53.77%123.41M | -4.62%27.19M |
| Net non-operating interest income (expenses) | 10.04%-699K | -2.73%-827K | 8.34%-758K | -0.22%-3.17M | 4.90%-757K | -0.13%-777K | -3.87%-805K | -1.85%-827K | -6.15%-3.16M | 1.61%-796K |
| Non-operating interest expense | -10.04%699K | 2.73%827K | -8.34%758K | 0.22%3.17M | -4.90%757K | 0.13%777K | 3.87%805K | 1.85%827K | 6.15%3.16M | -1.61%796K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -6.88%66.49M | -28.16%26.43M | -38.72%29.71M | 122.69%267.78M | 320.95%111.12M | 45.17%71.4M | 179.06%36.79M | 53.95%48.47M | -54.45%120.25M | -4.71%26.4M |
| Income tax | -11.62%14.11M | -25.82%6.77M | -39.56%7.22M | 118.63%63.14M | 357.14%26.11M | 40.84%15.97M | 142.45%9.12M | 48.02%11.95M | -46.18%28.88M | -35.33%5.71M |
| Net income | -5.51%52.38M | -28.94%19.66M | -38.44%22.49M | 123.97%204.64M | 310.95%85.01M | 46.47%55.43M | 193.68%27.67M | 56.00%36.53M | -56.56%91.37M | 9.62%20.69M |
| Net income continuous operations | -5.51%52.38M | -28.94%19.66M | -38.44%22.49M | 123.97%204.64M | 310.95%85.01M | 46.47%55.43M | 193.68%27.67M | 56.00%36.53M | -56.56%91.37M | 9.62%20.69M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -5.51%52.38M | -28.94%19.66M | -38.44%22.49M | 123.97%204.64M | 310.95%85.01M | 46.47%55.43M | 193.68%27.67M | 56.00%36.53M | -56.56%91.37M | 9.62%20.69M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -5.51%52.38M | -28.94%19.66M | -38.44%22.49M | 123.97%204.64M | 310.95%85.01M | 46.47%55.43M | 193.68%27.67M | 56.00%36.53M | -56.56%91.37M | 9.62%20.69M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -5.48%0.0655 | -28.90%0.0246 | -38.51%0.0281 | 123.88%0.2559 | 310.42%0.1063 | 46.51%0.0693 | 193.22%0.0346 | 55.97%0.0457 | -56.54%0.1143 | 9.75%0.0259 |
| Diluted earnings per share | -5.48%0.0655 | -28.90%0.0246 | -38.51%0.0281 | 123.88%0.2559 | 310.42%0.1063 | 46.51%0.0693 | 193.22%0.0346 | 55.97%0.0457 | -56.54%0.1143 | 9.76%0.0259 |
| Dividend per share | 0.00%0.015 | 0 | 107.55%0.11 | -20.00%0.068 | 0 | 0.00%0.015 | 0 | -24.29%0.053 | -58.54%0.085 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.